Franchini Indrani Lall Insider Trades

Insider Trading History

Track insider trading activity for Franchini Indrani Lall. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avanos Medical
Avanos Medical AVNS
Director
Holding Value $299k 12,003 shares
Last Trade
May 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$298k 12,003 shares
$24.80
$24.93
Avanos Medical
Avanos Medical AVNS
Director
Holding Value $419k 16,820 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$190k 12,003 shares
$15.83
$24.93
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $1.24M 4,320 shares
Last Trade
Feb 28, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$51.1k 329 shares
$155.30
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $505k 1,754 shares
Last Trade
Feb 27, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$140k 878 shares
$159.00
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $1.29M 4,462 shares
Last Trade
Feb 27, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$140k 878 shares
$159.00
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $1.35M 4,673 shares
Last Trade
Feb 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$272k 1,591 shares
$170.99
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $1.49M 5,175 shares
Last Trade
Feb 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$905k 5,175 shares
$174.92
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $1.49M 5,175 shares
Last Trade
Feb 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$905k 5,175 shares
$174.92
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $0 0 shares
Last Trade
Apr 06, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$735k 3,500 shares
$210.00
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $1.57M 5,449 shares
Last Trade
Feb 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.54M 8,081 shares
$190.01
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $1.47M 5,098 shares
Last Trade
Feb 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$379k 1,675 shares
$226.00
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $1.49M 5,175 shares
Last Trade
Feb 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.16M 5,175 shares
$224.91
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $2.98M 10,350 shares
Last Trade
Feb 01, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.16M 5,175 shares
$224.91
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, CLO & Secretary
Holding Value $8.41M 29,182 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.48M 44,707 shares
$144.93
$288.18
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Chief Compliance Officer
Holding Value $0 0 shares
Last Trade
Jul 21, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$21.2M 116,075 shares
$182.50
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Chief Compliance Officer
Holding Value $11.6M 63,450 shares
Last Trade
Jun 08, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$164k 928 shares
$177.00
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Chief Compliance Officer
Holding Value $11.7M 64,378 shares
Last Trade
Feb 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.75M 18,033 shares
$152.75
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Chief Compliance Officer
Holding Value $12.1M 66,183 shares
Last Trade
Dec 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6M 37,965 shares
$158.03
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Chief Compliance Officer
Holding Value $8.99M 49,258 shares
Last Trade
Dec 16, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.13M 19,838 shares
$157.96
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Chief Compliance Officer
Holding Value $6.4M 35,071 shares
Last Trade
Jun 08, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$161k 1,403 shares
$114.61
$182.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up